131 related articles for article (PubMed ID: 37864488)
1. Families with non-Hodgkin lymphoma and plasma cell dyscrasias in their pedigrees.
Wiernik PH; Dutcher JP
J Investig Med; 2024 Jan; 72(1):26-31. PubMed ID: 37864488
[TBL] [Abstract][Full Text] [Related]
2. Families with both Hodgkin lymphoma and multiple myeloma in their pedigrees.
Wiernik PH; Wickramasinghe D; Dutcher JP
Clin Adv Hematol Oncol; 2015 Apr; 13(4):257-60. PubMed ID: 26352584
[TBL] [Abstract][Full Text] [Related]
3. Familial myeloma and monoclonal gammopathy: a report of eight African American families.
Jain M; Ascensao J; Schechter GP
Am J Hematol; 2009 Jan; 84(1):34-8. PubMed ID: 19037864
[TBL] [Abstract][Full Text] [Related]
4. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
5. Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigree.
Alexandrescu DT; Garino A; Brown-Balem KA; Wiernik PH
Leuk Lymphoma; 2006 Oct; 47(10):2115-27. PubMed ID: 17071485
[TBL] [Abstract][Full Text] [Related]
6. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database.
Altieri A; Bermejo JL; Hemminki K
Blood; 2005 Jul; 106(2):668-72. PubMed ID: 15811955
[TBL] [Abstract][Full Text] [Related]
7. Clustering of cancer among families of cases with Hodgkin Lymphoma (HL), Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Soft Tissue Sarcoma (STS) and control subjects.
McDuffie HH; Pahwa P; Karunanayake CP; Spinelli JJ; Dosman JA
BMC Cancer; 2009 Feb; 9():70. PubMed ID: 19250521
[TBL] [Abstract][Full Text] [Related]
8. Anticipation in familial plasma cell dyscrasias.
Deshpande HA; Hu XP; Marino P; Jan NA; Wiernik PH
Br J Haematol; 1998 Dec; 103(3):696-703. PubMed ID: 9858219
[TBL] [Abstract][Full Text] [Related]
9. Familiality of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families.
Ogmundsdóttir HM; Haraldsdóttirm V; Jóhannesson GM; Olafsdóttir G; Bjarnadóttir K; Sigvaldason H; Tulinius H
Haematologica; 2005 Jan; 90(1):66-71. PubMed ID: 15642671
[TBL] [Abstract][Full Text] [Related]
10. Age of onset evidence for anticipation in familial non-Hodgkin's lymphoma.
Wiernik PH; Wang SQ; Hu XP; Marino P; Paietta E
Br J Haematol; 2000 Jan; 108(1):72-9. PubMed ID: 10651726
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families.
Dutcher JP; Wiernik PH; Varella L; Chintapatla R
Fam Cancer; 2016 Oct; 15(4):677-87. PubMed ID: 27334456
[TBL] [Abstract][Full Text] [Related]
12. B-cell maturation antigen expression across hematologic cancers: a systematic literature review.
Dogan A; Siegel D; Tran N; Fu A; Fowler J; Belani R; Landgren O
Blood Cancer J; 2020 Jun; 10(6):73. PubMed ID: 32606424
[TBL] [Abstract][Full Text] [Related]
13. Familial Waldenstrom's macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies--A population-based study from northern Sweden.
Brandefors L; Kimby E; Lundqvist K; Melin B; Lindh J
Acta Oncol; 2016; 55(1):91-8. PubMed ID: 26559865
[TBL] [Abstract][Full Text] [Related]
14. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
[TBL] [Abstract][Full Text] [Related]
15. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).
Wang SS; Slager SL; Brennan P; Holly EA; De Sanjose S; Bernstein L; Boffetta P; Cerhan JR; Maynadie M; Spinelli JJ; Chiu BC; Cocco PL; Mensah F; Zhang Y; Nieters A; Dal Maso L; Bracci PM; Costantini AS; Vineis P; Severson RK; Roman E; Cozen W; Weisenburger D; Davis S; Franceschi S; La Vecchia C; Foretova L; Becker N; Staines A; Vornanen M; Zheng T; Hartge P
Blood; 2007 Apr; 109(8):3479-88. PubMed ID: 17185468
[TBL] [Abstract][Full Text] [Related]
16. Nonrandom occurrence of lymphoid cancer types in 140 families.
Jones SJ; Voong J; Thomas R; English A; Schuetz J; Slack GW; Graham J; Connors JM; Brooks-Wilson A
Leuk Lymphoma; 2017 Sep; 58(9):1-10. PubMed ID: 28278712
[TBL] [Abstract][Full Text] [Related]
17. An overview of genetic predisposition to familial hematological malignancies.
Hamadou WS; Bouali N; Besbes S; Mani R; Bardakci F; Siddiqui AJ; Badraoui R; Adnan M; Sobol H; Soua Z
Bull Cancer; 2021; 108(7-8):718-724. PubMed ID: 34052033
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and Predictors of 30-Day Readmission in CAR-T Cell Therapy Recipients.
Sharma A; Singh V; Deol A
Transplant Cell Ther; 2023 Feb; 29(2):108.e1-108.e7. PubMed ID: 36371048
[TBL] [Abstract][Full Text] [Related]
19. Global burden of hematologic malignancies and evolution patterns over the past 30 years.
Zhang N; Wu J; Wang Q; Liang Y; Li X; Chen G; Ma L; Liu X; Zhou F
Blood Cancer J; 2023 May; 13(1):82. PubMed ID: 37193689
[TBL] [Abstract][Full Text] [Related]
20. Risk of Hematologic Malignancies in Elderly Patients With Ankylosing Spondylitis: A Cohort Study and Systematic Review.
Alehashemi S; Ward MM
Mayo Clin Proc; 2023 Jan; 98(1):100-110. PubMed ID: 36470752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
